Kora Saúde Participações Statistics

Total Valuation

BVMF:KRSA3 has a market cap or net worth of BRL 682.15 million. The enterprise value is 3.53 billion.

Market Cap	682.15M
Enterprise Value	3.53B

Important Dates

The last earnings date was Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

BVMF:KRSA3 has 76.90 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	n/a
Shares Outstanding	76.90M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	14.91%
Owned by Institutions (%)	7.08%
Float	17.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.30
PB Ratio	0.74
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.08, with an EV/FCF ratio of -21.69.

EV / Earnings	-19.90
EV / Sales	1.55
EV / EBITDA	8.08
EV / EBIT	13.21
EV / FCF	-21.69

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 3.25.

Current Ratio	2.00
Quick Ratio	1.82
Debt / Equity	3.25
Debt / EBITDA	6.88
Debt / FCF	-18.39
Interest Coverage	0.74

Financial Efficiency

Return on equity (ROE) is -16.80% and return on invested capital (ROIC) is 4.28%.

Return on Equity (ROE)	-16.80%
Return on Assets (ROA)	3.50%
Return on Invested Capital (ROIC)	4.28%
Return on Capital Employed (ROCE)	6.47%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.48
Inventory Turnover	23.21

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.19% in the last 52 weeks. The beta is 0.99, so BVMF:KRSA3's price volatility has been similar to the market average.

Beta (5Y)	0.99
52-Week Price Change	+23.19%
50-Day Moving Average	8.72
200-Day Moving Average	7.04
Relative Strength Index (RSI)	60.05
Average Volume (20 Days)	53,100

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BVMF:KRSA3 had revenue of BRL 2.27 billion and -177.28 million in losses. Loss per share was -2.29.

Revenue	2.27B
Gross Profit	454.28M
Operating Income	265.18M
Pretax Income	-173.92M
Net Income	-177.28M
EBITDA	399.09M
EBIT	265.18M
Loss Per Share	-2.29

Full Income Statement

Balance Sheet

The company has 252.68 million in cash and 2.99 billion in debt, giving a net cash position of -2.74 billion or -35.61 per share.

Cash & Cash Equivalents	252.68M
Total Debt	2.99B
Net Cash	-2.74B
Net Cash Per Share	-35.61
Equity (Book Value)	919.86M
Book Value Per Share	10.58
Working Capital	679.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -115.33 million and capital expenditures -47.30 million, giving a free cash flow of -162.63 million.

Operating Cash Flow	-115.33M
Capital Expenditures	-47.30M
Free Cash Flow	-162.63M
FCF Per Share	-2.11

Full Cash Flow Statement

Margins

Gross margin is 20.03%, with operating and profit margins of 11.69% and -7.82%.

Gross Margin	20.03%
Operating Margin	11.69%
Pretax Margin	-7.67%
Profit Margin	-7.82%
EBITDA Margin	17.59%
EBIT Margin	11.69%
FCF Margin	n/a

Dividends & Yields

BVMF:KRSA3 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	-25.99%
FCF Yield	-23.84%

Stock Splits

The last stock split was on October 11, 2024. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 11, 2024
Split Type	Reverse
Split Ratio	0.1

Scores

BVMF:KRSA3 has an Altman Z-Score of 0.77. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.77
Piotroski F-Score	n/a